Missing/wrong data?
Log in to edit
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
scientific article
Author/s
author: Eduard Montanya, Giorgio Sesti, Julio Rosenstock, John Buse, Edelmiro Menéndez Torre, Marcin J Zychma
Work details
Publication date
June 8, 2009
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.